Caso contributivo
Sferocitosi: una famiglia... tre malattie!
Hereditary Spherocytosis: different clinical presentations in the same family
Dante Ferrara1, Chiara Giordano2, Zelia Borsellino3, Liana Cuccia3, Giovan Battista Ruffo3,
Giovanni Corsello2
1Pediatra di famiglia ASP 6 Palermo, Scuola di Specializzazione in Pediatria, Università di Palermo
2Scuola di Specializzazione in Pediatria, Dipartimento di Scienze per la Promozione della Salute
e Materno Infantile “G. D’Alessandro”, Università di Palermo
3UO di Ematologia e Talassemia, ARNAS Ospedali Civico Di Cristina Benfratelli, Palermo
Gennaio 2024 | DOI: 10.53126/MEBXXVIIG5
Abstract
The paper describes the cases of three siblings affected by Hereditary Spherocytosis (HS). The different clinical presentations in the same family are examples of the heterogeneity of this pathology. HS is a common inherited type of haemolytic anaemia that results from abnormal morphology of erythrocytes. The clinical spectrum of HS ranges from asymptomatic forms characterized by well-compensated chronic haemolysis to severe forms with high transfusion requirement. The typical symptoms triad is anaemia, jaundice and splenomegaly while the most common complication is cholelithiasis. The diagnosis of hereditary spherocytosis in the neonate can be difficult, due to different clinical and laboratory presentations. Neonatal HS ratio, calculated by dividing the MCHC by the MCV, is a rapid and inexpensive screening. Splenectomy helps improve the patient’s quality of life and may be performed after six years of age. RHuEPO therapy should be considered in affected infants with high transfusion requirement.
Contenuto riservato
Per leggere l'articolo è necessario effettuare il login.
Parole chiave
